Locally Delivered 1% Metformin Gel in Peri-implantitis
Status:
Completed
Trial end date:
2017-07-24
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy of 1% local metformin gel in deep periimplant pockets of
type 2 diabetes mellitus patients. Half of the participants will receive 1% metformin gel
with manual debridement while the other half will receive a placebo with manual debridement.